These findings provide evidence that NLRP4 plays a role in promoting the DNA damage response and ROS-induced autophagy, thereby conferring resistance to olaparib on pancreatic cancer cells (Fig. 9i). This evidence concerns the gene NLRP4 and pancreatic neoplasm.